National Psoriasis Foundation opens grant applications for psoriatic disease cure research

The National Psoriasis Foundation has opened applications for its Milestones to a Cure research grant program, with awards of up to $500,000 over two years. The funding aims to support studies that could help drive durable remission and move psoriatic disease closer to a cure.

Why it matters: - Psoriatic disease affects more than 8 million people in the United States. - The grant program is aimed at research that could help answer the remaining scientific questions standing between current treatments and a cure. - Selected projects can receive up to $500,000, giving researchers support for longer-term, high-impact studies.

What happened: - The National Psoriasis Foundation opened applications for its Milestones to a Cure research grant program on August 12, 2026. - The funding initiative is designed to accelerate discoveries that could lead to durable remission and, eventually, a cure for psoriatic disease. - NPF is inviting investigators from a broad range of disciplines to apply.

The details: - Areas of interest include novel approaches to complete remission and relapse prevention. - The program is also seeking proposals on immune memory and durable remission. - Other priority topics include markers of ongoing disease activity, links between psoriatic disease and comorbidities, and personalized approaches to disease control and immune homeostasis. - Selected projects may receive funding for a two-year project period. - Awards can be up to $250,000 per year. - The maximum total award is $500,000, including up to 10% indirect costs. - The full Request for Proposals and application instructions are available online. - Questions about the funding opportunity can be sent to research@psoriasis.org.

Between the lines: - NPF is signaling that the next breakthroughs may come from work that goes beyond symptom control and targets the biology of remission itself. - The focus on comorbidities and personalized treatment suggests the foundation wants research that can translate into more precise care, not just broader disease suppression. - The program also reflects NPF's role as a major funder in a field where unanswered questions remain despite treatment advances.

What's next: - Letter of intent submissions are due August 31, 2026. - NPF will notify applicants about LOIs on September 21, 2026. - Full applications are due December 1, 2026. - Award notifications are set for March 1, 2027. - Funding is scheduled to begin May 1, 2027. - Researchers can direct questions to research@psoriasis.org.

The bottom line: - NPF is putting new funding behind research it sees as essential to moving psoriatic disease from long-term management toward remission and a cure.